Study guide
8.3 Gynecology: Menstruation, Menopause, PCOS, and Vaginal Infections
NCCPA PANCE Physician Assistant Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Cardiovascular System
1.1 Hypertension (Essential & Secondary) 1.2 Coronary Artery Disease & Myocardial Infarction 1.3 Heart Failure & Cardiomyopathy 1.4 Cardiac Arrhythmias & Conduction Disorders 1.5 Valvular Heart Disease 1.6 Vascular Diseases (Aortic Aneurysm, PAD, DVT) 1.7 Congenital Heart Disease (ASD, VSD, PDA, Coarctation, Tetralogy of Fallot)
2 Chapter 2: Pulmonary System
Section 2.1: Asthma & Bronchospastic Disease Section 2.2: Chronic Obstructive Pulmonary Disease (COPD) Section 2.3: Infectious Pulmonary Disorders (Pneumonia & Tuberculosis) Section 2.4: Restrictive, Vascular & Neoplastic Pulmonary Conditions
3 Chapter 3: Gastrointestinal/Nutrition
3.1 Esophageal & Gastric Disorders (GERD, PUD) 3.2 Hepatic, Biliary & Pancreatic Disorders 3.3 Small & Large Bowel Disorders (IBD, Diverticulitis, Obstruction) 3.4 Colorectal Neoplasms & Nutritional Deficiencies
4 Chapter 4: Musculoskeletal System
Section 4.1: Rheumatologic & Autoimmune MSK Conditions (RA, Lupus, Gout, OA) Section 4.2: Infectious & Inflammatory MSK Disorders (Osteomyelitis, Septic Arthritis) Section 4.3: Bone & Joint Disorders (Fractures, Osteoporosis, Fibromyalgia) Section 4.4: Spine and Soft Tissue Pathology (Low Back Pain, Tendonitis)
5 Chapter 5: Neurologic System
Section 5.1: Cerebrovascular Disease (Stroke, TIA) Section 5.2: Seizure Disorders & Epilepsy Section 5.3: Demyelinating & Neurodegenerative Diseases Section 5.4: Headache Syndromes & Cranial Nerve Disorders
6 Chapter 6: Psychiatry/Behavioral Science
Section 6.1: Depressive and Bipolar Disorders Section 6.2: Anxiety, Trauma-Related, and Obsessive-Compulsive Disorders Section 6.3: Schizophrenia and Psychotic Disorders Section 6.4: Eating, Substance Use, and Personality Disorders
7 Chapter 7: Infectious Diseases
7.1 Viral Infections (HIV, EBV, Influenza) 7.2 Bacterial & Spirochetal Infections (Sepsis, Meningitis) 7.3 Fungal & Parasitic Infections 7.4 Tick-Borne Diseases (Lyme, Rocky Mountain Spotted Fever)
8 Chapter 8: Reproductive System
8.1 Obstetrics: Normal Pregnancy & Prenatal Care 8.2 Obstetrics: Pregnancy Complications 8.3 Gynecology: Menstruation, Menopause, PCOS, and Vaginal Infections
9 Chapter 9: Endocrine System
Section 9.1: Diabetes Mellitus & Acute Complications Section 9.2: Thyroid Disorders & Goiter Section 9.3: Adrenal & Pituitary Disorders
10 Chapter 10: Eyes, Ears, Nose, and Throat
Section 10.1: Ophthalmic Disorders (Glaucoma, Conjunctivitis, Cataracts) Section 10.2: Otic Disorders (Otitis Media/Externa, Vertigo, Labyrinthitis) Section 10.3: Nose, Sinus, and Throat Complaints (Sinusitis, Pharyngitis, Epiglottitis)
11 Chapter 11: Professional Practice
11.1 Bioethics & Legal Standards (Informed Consent, Autonomy, HIPAA) 11.2 Patient Safety, Quality Improvement, and Communication 11.3 Evidence-Based Medicine & Clinical Practice Guidelines
12 Chapter 12: Hematologic System
Section 12.1: Anemias (Microcytic, Macrocytic, Hemolytic/Sickle Cell) Section 12.2: Coagulation and Bleeding Disorders (ITP, TTP, Hemophilia, vWD) Section 12.3: Hematologic Malignancies (Leukemia, Lymphoma, Multiple Myeloma)
13 Chapter 13: Renal System
13.1 Acute Kidney Injury (AKI) & Chronic Kidney Disease (CKD) 13.2 Acid-Base and Electrolyte Disorders 13.3 Glomerular & Tubulointerstitial Diseases
14 Chapter 14: Dermatologic System
Section 14.1: Inflammatory & Autoimmune Skin Conditions Section 14.2: Infectious Skin Conditions Section 14.3: Skin Neoplasms & Burn Management
15 Chapter 15: Genitourinary System
Section 15.1: Male Genitourinary Disorders (BPH, Prostate Cancer, Testicular Torsion, ED) Section 15.2: Urinary Incontinence, Nephrolithiasis, and GU Trauma
8.3 Gynecology: Menstruation, Menopause, PCOS, and Vaginal Infections
Key Takeaways Explain This Topic AI
Postmenopausal bleeding is endometrial cancer until proven otherwise, requiring transvaginal ultrasound and endometrial biopsy if the stripe is > 4 mm.
In menopause management, women with an intact uterus must receive combined estrogen and progesterone therapy to avoid unopposed estrogen-induced endometrial cancer.
PCOS is diagnosed using the Rotterdam criteria and presents a high long-term risk of endometrial adenocarcinoma due to chronic anovulation.
Bacterial vaginosis is characterized by clue cells and an elevated pH, whereas candidiasis presents with normal pH and pseudohyphae/yeast on KOH prep.
Metronidazole therapy for BV or Trichomoniasis requires strict avoidance of alcohol to prevent a severe disulfiram-like reaction.
Last updated: July 2026
- Gynecology: Menstruation, Menopause, PCOS, and Vaginal Infections
- Why This Matters for PANCE
Gynecologic pathology represents a high-yield outpatient focus on the PANCE. You must master the PALM-COEIN classification of abnormal uterine bleeding, the clinical evaluation of postmenopausal bleeding, the diagnostic criteria and systemic complications of PCOS, and the microscopic and clinical differences between the three major vaginal infections.
Abnormal Uterine Bleeding (AUB)
Abnormal Uterine Bleeding (AUB) refers to any menstrual bleeding that deviates from normal frequency, duration, or volume.
PALM-COEIN Classification:
Structural (PALM): P olyp (hyperplastic epithelial overgrowths), A denomyosis (endometrial tissue within the myometrium, presenting with a globally enlarged, symmetric, boggy, and tender uterus), L eiomyoma (uterine fibroids, presenting with an asymmetric, firm, non-tender uterus), and M alignancy/hyperplasia.
Non-Structural (COEIN): C oagulopathy (e.g., von Willebrand disease, especially in adolescents with heavy menses since menarche), O vulatory dysfunction (e.g., PCOS, hypothyroidism, or perimenopause, causing irregular bleeding), E ndometrial (primary dysfunction of endometrial local hemostasis), I atrogenic (due to anticoagulants, IUDs, or hormonal contraceptives), and N ot yet classified.
Diagnostic Workup:
Initial Test: Transvaginal ultrasound (TVUS) to assess endometrial thickness and rule out structural pathologies.
Endometrial Biopsy (EMB): Indicated in all women aged >= 45 years with AUB. In women < 45 years , EMB is indicated if there is a history of unopposed estrogen exposure (e.g., chronic anovulation in PCOS), obesity, or failed medical management.
Postmenopausal Bleeding: Any vaginal bleeding occurring >= 12 months after the cessation of menses is considered endometrial cancer until proven otherwise. A TVUS is performed first. If the endometrial stripe is > 4 mm (or if bleeding is persistent), an endometrial biopsy is mandatory.
Menopause
Menopause is the permanent cessation of menses due to the loss of ovarian follicular activity.
Definition & Diagnosis: Defined retrospectively as 12 consecutive months of amenorrhea without another physiological cause. The average age is 51. Diagnosis is clinical. Laboratory evaluation is generally unnecessary but will show a marked elevation in Follicle-Stimulating Hormone (FSH) > 30 mIU/mL due to the loss of negative feedback from estradiol.
Clinical Presentation: Vasomotor symptoms (hot flashes, night sweats), sleep disturbances, mood changes, and the Genitourinary Syndrome of Menopause (vaginal dryness, burning, dyspareunia, and recurrent UTIs due to vaginal pH rising above 4.5 and loss of tissue elasticity).
Hormone Replacement Therapy (HRT) Safety Rules:
Intact Uterus: Women with an intact uterus MUST receive combined estrogen-progesterone therapy. Unopposed estrogen therapy leads to endometrial hyperplasia and a high risk of endometrial cancer.
Prior Hysterectomy: Women who have undergone a hysterectomy can safely receive estrogen-only therapy.
Contraindications to Systemic HRT: History of breast cancer, estrogen-dependent cancers, active thromboembolic disease (DVT/PE), history of stroke or myocardial infarction, active liver disease, or undiagnosed abnormal vaginal bleeding.
Vaginal Estrogen: For isolated vulvovaginal symptoms (vaginal dryness/atrophy), low-dose topical vaginal estrogen is preferred and carries minimal systemic absorption.
Polycystic Ovary Syndrome (PCOS)
PCOS is a common endocrine disorder characterized by insulin resistance and hyperandrogenism.
Pathophysiology: Insulin resistance leads to compensatory hyperinsulinemia. Insulin acts synergistically with luteinizing hormone (LH) to stimulate androgen production by ovarian theca cells. Insulin also suppresses hepatic production of Sex Hormone-Binding Globulin (SHBG), which increases free testosterone. Furthermore, an abnormal GnRH pulsatility results in an elevated LH-to-FSH ratio (often > 2:1 or 3:1), which prevents follicle maturation, causing chronic anovulation.
Rotterdam Criteria: Diagnosis requires at least two of the following three :
Oligomenorrhea or anovulation (irregular or absent menstrual cycles).
Clinical or biochemical hyperandrogenism (hirsutism, acne, male-pattern baldness, or elevated free/total testosterone).
Polycystic ovaries on ultrasound (multiple peripheral subcentimeter follicles resembling a "string of pearls" or ovarian volume > 10 mL).
Clinical Presentation and Risks: Patients present with obesity, hirsutism, acne, and acanthosis nigricans (velvety, hyperpigmented plaques on intertriginous areas indicating insulin resistance). Long-term risks include type 2 diabetes, metabolic syndrome, obstructive sleep apnea, cardiovascular disease, and a significantly increased risk of endometrial adenocarcinoma due to chronic unopposed estrogen (lack of progesterone protection due to anovulation).
Management:
First-Line (General): Lifestyle modifications (weight loss and exercise) to improve insulin sensitivity and restore ovulation.
Cycle Regulation & Hirsutism: Combined Oral Contraceptives (COCs) are the first-line pharmacotherapy. The progesterone component protects the endometrium, and the estrogen increases SHBG to lower free testosterone.
Insulin Resistance: Metformin.
Refractory Hirsutism: Spironolactone (an anti-androgen). Warning: Due to risk of teratogenicity (feminization of a male fetus), it must be paired with effective contraception.
Infertility/Ovulation Induction: Letrozole (aromatase inhibitor, first-line) or clomiphene.
Vaginitis (Vaginal Infections)
Differentiating the three major causes of vaginal discharge is a highly tested clinical skill.
- Diagnostic Feature Bacterial Vaginosis Vulvovaginal Candidiasis Trichomoniasis
- Pathogen Gardnerella vaginalis & anaerobes Candida albicans (fungus) Trichomonas vaginalis (protozoan)
Discharge Character Thin, homogeneous, gray-white Thick, white, clumpy ("cottage cheese") Copious, frothy, yellow-green
Odor Foul, fishy (positive amine/whiff test) None Malodorous
Vaginal/Vulvar Exam Normal vaginal wall, no inflammation Erythema, pruritus, excoriations Erythema, pruritus, strawberry cervix
Vaginal pH Elevated (> 4.5) Normal (4.0 - 4.5) Elevated (> 4.5)
Wet Mount / Microscopy Clue cells on saline wet mount Pseudohyphae & budding yeast on KOH Motile flagellated protozoa on saline
First-line Treatment Oral Metronidazole or topical Clindamycin Oral Fluconazole or topical azoles Oral Metronidazole (treat partner!)
Bacterial Vaginosis (BV): A non-STI dysbiosis caused by a loss of lactobacilli and overgrowth of anaerobes like Gardnerella vaginalis . Diagnosed via the Amsel criteria: thin gray-white discharge, pH > 4.5, positive whiff test (with 10% KOH), and clue cells on saline wet mount (epithelial cells covered in bacteria obscuring the cell border). Treatment is oral Metronidazole 500 mg BID for 7 days. Pearl: Patients must avoid alcohol during and for 48 hours after treatment to prevent a disulfiram-like reaction.
Vulvovaginal Candidiasis: Fungal overgrowth, often after antibiotic use. Presents with intense pruritus, erythema, and a thick, white, clumpy, "cottage cheese-like" discharge. Vaginal pH is normal (4.0-4.5) . Microscopic examination on KOH prep shows pseudohyphae and budding yeast . Treatment is a single dose of oral Fluconazole (150 mg) .
Trichomoniasis: An STI caused by the flagellated protozoan Trichomonas vaginalis . Presents with a copious, frothy, yellow-green, malodorous discharge, and a strawberry cervix (cervical petechiae). Vaginal pH is > 4.5. Saline wet mount shows motile flagellated trichomonads . Treatment is oral Metronidazole (500 mg BID for 7 days). Must treat sexual partners and counsel to avoid alcohol.
Endometriosis
Endometriosis is the presence of functional endometrial glands and stroma outside the uterine cavity , most commonly on the ovaries, fallopian tubes, pelvic peritoneum, and cul-de-sac. It is an important reproductive blueprint topic.
Pathophysiology: Retrograde menstruation is the leading theory — endometrial tissue flows backward through the fallopian tubes and implants on pelvic structures. These ectopic implants respond to cyclic hormonal stimulation, causing inflammation, adhesions, and endometriomas ("chocolate cysts" on the ovaries).
Clinical Presentation: The classic triad is chronic pelvic pain, dysmenorrhea, and dyspareunia (painful intercourse). Pain often begins before menses. Infertility may be the presenting complaint. Severity of symptoms does NOT correlate well with the extent of disease.
Physical Exam: Fixed, retroverted uterus; tender adnexa; nodularity of the uterosacral ligaments on bimanual/vaginal exam; tender posterior fornix.
Imaging: Pelvic ultrasound may show endometriomas (homogeneous, low-level echo "chocolate" cysts). MRI is more sensitive for deep infiltrating disease. Definitive diagnosis requires diagnostic laparoscopy with biopsy showing endometrial glands and stroma outside the uterus.
Management:
NSAIDs — first-line for mild pain.
Hormonal suppression — combined oral contraceptives (cyclic or continuous), progestins (e.g., medroxyprogesterone, norethindrone), or the levonorgestrel IUD. Goal: suppress menstrual cycling and ectopic endometrial growth.
GnRH agonists (e.g., leuprolide) — for severe refractory disease. Induces a temporary menopausal state. Add-back therapy (norethindrone or low-dose estrogen) is given to prevent bone loss and vasomotor symptoms.
Surgery — laparoscopic ablation/excision for refractory pain, large endometriomas, or infertility. Hysterectomy with bilateral salpingo-oophorectomy is definitive for severe disease in patients who have completed childbearing.
PANCE Trap — Endometriosis vs. Adenomyosis: Endometriosis is endometrial tissue outside the uterus and presents with dyspareunia and nodular uterosacral ligaments. Adenomyosis is endometrial tissue within the myometrium and presents with a symmetrically enlarged, boggy, tender uterus and menorrhagia. Both cause dysmenorrhea.
Classic PANCE Traps & Clinical Pearls
Metronidazole Alcohol Warning: Always counsel patients to avoid alcohol with metronidazole. This applies to both BV and Trichomoniasis treatments.
pH is the Key: Candidiasis is the only one of the three with a normal vaginal pH (4.0-4.5). An elevated pH (>4.5) points to BV or Trichomoniasis.
Adenomyosis vs. Fibroids: Adenomyosis presents with a globally enlarged, symmetrically boggy, and tender uterus. Fibroids present with an asymmetrically enlarged, firm, and non-tender uterus. Both cause heavy menstrual bleeding.